The current treatment of erectile dysfunction

The current treatment of erectile dysfunction

Erectile dysfunction (ED) is the inability to achieve and maintain an erection sufficient for satisfactory sexual intercourse. It is the most frequent sexual dysfunction in elderly men and its prevalence increases with age. Ever since ED was recognized as a real health problem, several treatment op...

Full description

Bibliographic Details
Main Authors:	Maria Isabela Sarbu, Mircea Tampa, Mădălina I. Mitran, Cristina I. Mitran, Vasile Benea
Format:	Article
Language:	English
Published:	Ion Motofei, Carol Davila University 2016-10-01
Series:	Journal of Mind and Medical Sciences
Subjects:	erectile dysfunction PDE5 inhibitors alprostadil vacuum erection devices
Online Access:	http://scholar.valpo.edu/cgi/viewcontent.cgi?article=1054&context=jmms

Similar Items

Alprostadil plus Vacuum (VITARUM) in severe erectile dysfunction (ED)
by: Franco Mantovani
Published: (2017-06-01)

To evaluate the etiology of erectile dysfunction: What should we know currently?
by: Orcun Celik, et al.
Published: (2014-09-01)

Management of male erectile dysfunction: From the past to the future
by: Chang-Ming Wang, et al.
Published: (2023-02-01)

Is There a Space to Improve the Treatment of Erectile Dysfunction in the Next Years? Opinion: No. Ten reasons that there will be no new pharmacologic therapies for erectile dysfunctionin the foreseeable future
by: Ira D. Sharlip
Published: (2015-10-01)

Is There a Space to Improve the Treatment of Erectile Dysfunction in the Next Years? Opinion: Yes
by: Stanley E. Althof
Published: (2015-10-01)

Erectile Dysfunction: Treatments, Advances and New Therapeutic Strategies
by: Antonio Argiolas, et al.
Published: (2023-05-01)

Erectile Dysfunction: A Primer for in Office Management
by: Samir Sami, et al.
Published: (2019-08-01)

Endovascular treatment of vasculogenic erectile dysfunction
by: Edward D Kim, et al.
Published: (2015-02-01)

TREATMENT OF ERECTILE DYSFUNCTION IN PATIENTS WITH PROSTATE TUMOR AFTER RADICAL PROSTATECTOMY
by: A. V. Babintsev, et al.
Published: (2017-05-01)

Penile Rehabilitation and Treatment Options for Erectile Dysfunction Following Radical Prostatectomy and Radiotherapy: A Systematic Review
by: Melianthe Nicolai, et al.
Published: (2021-03-01)

PDE-5 inhibitors in monotherapy versus combination therapy in a sample of 1200 patients with erectile dysfunction
by: Luis Labairu-Huerta, et al.
Published: (2015-09-01)

Adherence to Phosphodiesterase Type 5 Inhibitors in the Treatment of Erectile Dysfunction in Long-Term Users: How Do Men Use the Inhibitors?
by: Ana Carvalheira, PhD, et al.
Published: (2014-06-01)

Erectile dysfunction as a manifestation of urogenital autonomic neuropathy in patients with type 1 diabetes: epidemiology, classification, pathophysiology, diagnosis and treatment options
by: Gagik Radikovich Galstyan, et al.
Published: (2014-07-01)

Recreation use of phosphodiesterase type 5 inhibitors, the other side of erectile dysfunction
by: Giovanni Maria Fusco, et al.
Published: (2023-05-01)

Causal effects of hypertension on risk of erectile dysfunction: A two-sample Mendelian randomization study
by: Zheng Wang, et al.
Published: (2023-03-01)

A survey on the experience of 136 Italian urologists in the treatment of erectile dysfunction with PDE5 inhibitors and recommendations for the use of Avanafil in the clinical practice
by: Vincenzo Mirone, et al.
Published: (2016-07-01)

Emerging structural and pathological analyses on the erectile organ, corpus cavernous containing sinusoids
by: Daiki Hashimoto, et al.
Published: (2023-01-01)

Justification of vacuum prophylaxis as part of the penile rehabilitation in patients after nerve-sparing radical prostatectomy
by: A. E. Osadchinskiy, et al.
Published: (2021-12-01)

Endothelial Dysfunction, Erectile Dysfunction and Phosphodiesterase 5 Inhibitors. An Update of the Current Data and Future Perspectives
by: Angelis Konstantinopoulos, et al.
Published: (2007-01-01)

Erectile dysfunction: current situation
by: N. D. Akhvlediani, et al.
Published: (2015-12-01)

Sexual dysfunctions in psoriatic patients
by: Maria Isabela Sarbu, et al.
Published: (2015-04-01)

Comparing the Effects of Vacuum Constrictive Devices and Intra-Cavernosal Injection of Papaverine for Erectile Dysfunction Treatment
by: Amir Ghasemlouei, et al.
Published: (2021-07-01)

Pharmacotherapy of erectile dysfunction: Current standards
by: Kew-Kim Chew
Published: (2006-01-01)

Safety and efficacy of sildenafil in Brazilian men with erectile dysfunction secondary to spinal cord injury
by: Carlos Eurico Dornelles Cairoli, et al.
Published: (2008-03-01)

A prospective randomized controlled study on scheduled PDE5i and vacuum erectile devices in the treatment of erectile dysfunction after nerve sparing prostatectomy
by: Ming Zhang, et al.
Published: (2022-01-01)

The Role of Long Term Label-Retaining Cells in the Treatment of Erectile Dysfunction by Vacuum Erectile Device
by: Baibing Yang, MD, PhD, et al.
Published: (2021-12-01)

The Race to Replace PDE5i: Recent Advances and Interventions to Treat or Manage Erectile Dysfunction: Evidence from Patent Landscape (2016–2021)
by: Mohammed Monirul Islam, et al.
Published: (2022-05-01)

The blue pill (sildenafil) and its descendants: an overview
by: Krzanowski Tomasz, et al.
Published: (2017-09-01)

A Prospective, Randomized, Double-Blinded, Clinical Trial Using a Second-Generation Duolith SD1 Low-Intensity Shockwave Machine in Males with Vascular Erectile Dysfunction
by: Eric Chung, et al.
Published: (2023-01-01)

The Impact of Vacuum Constrictive Device on the Treatment of Erectile Dysfunction in Spinal Cord Injured patients
by: Feraidoon Khayyamfar, et al.
Published: (2021-12-01)

Incidental findings during computed tomographic angiography diagnostic work-up in patients with arteriogenic erectile dysfunction
by: Jan Schönhofen, et al.
Published: (2019-12-01)

Influence of regular use of vardenafil on endothelial and erectile functions in patients with arteriogenic erectile dysfunction
by: Safar Israilovich Gamidov, et al.
Published: (2009-10-01)

Neurogenic Erectile Dysfunction. Where Do We Stand?
by: Charalampos Thomas, et al.
Published: (2021-01-01)

Obesity and Erectile Dysfunction: From Bench to Clinical Implication
by: Ki Hak Moon, et al.
Published: (2019-05-01)

Peyronie′s disease and erectile dysfunction: Current understanding and future direction
by: Laurence A Levine
Published: (2006-01-01)

Erectile Dysfunction Severity: The Role of Glycometabolic Compensation and Antihyperglycemic Drugs
by: Virginia Zamponi, et al.
Published: (2022-12-01)

Androgen Deficiency and Phosphodiesterase Type 5 Expression Changes in Aging Male: Therapeutic Implications
by: Antonio Aversa, et al.
Published: (2019-04-01)

The pharmacological management of erectile dysfunction
by: Andre Marais
Published: (2015-07-01)

Erectile dysfunction in diabetes mellitus: A review
by: Deepak K Jumani, et al.
Published: (2020-01-01)

The Effect of Alcohol Administration on the Corpus Cavernosum
by: See Min Choi, et al.
Published: (2017-04-01)